Early Mortality in a Multinational Systemic Sclerosis Inception Cohort

To determine mortality and causes of death in a multinational inception cohort of subjects with systemic sclerosis (SSc).

[1]  M. Fine,et al.  Derivation and External Validation of a Prediction Rule for Five‐Year Mortality in Patients With Early Diffuse Cutaneous Systemic Sclerosis , 2015, Arthritis & rheumatology.

[2]  Y. Asano,et al.  Vasculopathy in scleroderma , 2015, Seminars in Immunopathology.

[3]  C. Denton.  Systemic sclerosis: from pathogenesis to targeted therapy. , 2015, Clinical and experimental rheumatology.

[4]  A. Wells,et al.  Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis , 2014, Arthritis & rheumatology.

[5]  E. Krishnan,et al.  Atherosclerotic Cardiovascular Disease in Hospitalized Patients With Systemic Sclerosis: Higher Mortality Than Patients With Lupus and Rheumatoid Arthritis , 2014, Arthritis care & research.

[6]  M. Humbert,et al.  Survival and prognostic factors in systemic sclerosis-associated pulmonary hypertension: a systematic review and meta-analysis. , 2013, Arthritis and rheumatism.

[7]  J. Gran,et al.  Survival and Causes of Death in an Unselected and Complete Cohort of Norwegian Patients with Systemic Sclerosis , 2013, The Journal of Rheumatology.

[8]  G. Shaddick,et al.  Mortality in systemic sclerosis—a single centre study from the UK , 2013, Clinical Rheumatology.

[9]  P. Sampaio-Barros,et al.  Survival, Causes of Death, and Prognostic Factors in Systemic Sclerosis: Analysis of 947 Brazilian Patients , 2012, The Journal of Rheumatology.

[10]  Y. Allanore,et al.  Trends in mortality in patients with systemic sclerosis over 40 years: a systematic review and meta-analysis of cohort studies. , 2012, Rheumatology.

[11]  I. Wicks,et al.  Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis , 2012, Annals of the rheumatic diseases.

[12]  P. Nash,et al.  Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort , 2011, Arthritis research & therapy.

[13]  A. Gabrielli,et al.  Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres , 2011, Annals of the rheumatic diseases.

[14]  C. Mok,et al.  Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. , 2011, Arthritis and rheumatism.

[15]  G. Valentini,et al.  [Survival and death causes in 251 systemic sclerosis patients from a single Italian center]. , 2011, Reumatismo.

[16]  E. Feierl,et al.  Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database , 2010, Annals of the rheumatic diseases.

[17]  L. Carmona,et al.  Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital. , 2010, Seminars in arthritis and rheumatism.

[18]  M. Gershwin,et al.  The immunobiology of systemic sclerosis. , 2008, Seminars in arthritis and rheumatism.

[19]  T. Medsger,et al.  Changes in causes of death in systemic sclerosis, 1972–2002 , 2007, Annals of the rheumatic diseases.

[20]  T. Krieg,et al.  [Pathogenesis of systemic sclerosis]. , 2007, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[21]  C. Denton,et al.  Systemic sclerosis associated pulmonary hypertension: improved survival in the current era , 2005, Heart.

[22]  A. Wiik,et al.  Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis. , 2001, The Journal of rheumatology.

[23]  A. Silman,et al.  Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. , 1999, Arthritis and rheumatism.

[24]  S. Ullman,et al.  Mortality and causes of death of 344 Danish patients with systemic sclerosis (scleroderma) , 1998, British journal of rheumatology.

[25]  A. Silman,et al.  Survival following the onset of scleroderma: results from a retrospective inception cohort study of the UK patient population. , 1996, British journal of rheumatology.

[26]  Niels Keiding,et al.  Statistical Models Based on Counting Processes , 1993 .

[27]  P. Lachenbruch,et al.  Early Undifferentiated Connective Tissue Disease: III. Outcome and Prognostic Indicators in Early Scleroderma (Systemic Sclerosis) , 1993, Annals of Internal Medicine.

[28]  C. Newell.  Methods and Models in Demography , 1988 .

[29]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[30]  P. Holt,et al.  Survival in scleroderma. , 1971, Annals of the rheumatic diseases.

[31]  C. L. Chiang,et al.  Introduction to stochastic processes in biostatistics. , 1968 .

[32]  C. Chiang.  The life table and its construction , 1968 .